Ottawa biotech firm Avivagen’s revenues slip on mistimed sales cycle
Local biotech firm Avivagen hit a snag in revenues this past quarter even as the firm continues to secure regulatory approvals for its alternative to
Ottawa biotech firm Avivagen’s revenues slip on mistimed sales cycle
Local biotech firm Avivagen hit a snag in revenues this past quarter even as the firm continues to secure regulatory approvals for its alternative to
Ottawa biotech firm Avivagen closes $5.3M financing amid U.S. market push
An Ottawa-based biotech firm that makes a line of natural health products designed to replace antibiotics in livestock feed has announced a multimillion-dollar funding round
Life sciences firm Avivagen raises $3.6M in private placement
Avivagen CEO Cameron Groome was sounding an upbeat tone Friday morning after his company announced it had secured $3.6 million in new funding in a
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored